Skip to main content

Table 2 Patient Global Impression of Change at final assessment

From: A randomized, double-blind, multicenter, placebo-controlled phase III trial to evaluate the efficacy and safety of pregabalin in Japanese patients with fibromyalgia

 

Placebo

Pregabalin

Number assesseda

247

249

Very much improved

16 (6.5)b

31 (12.4)

Much improved

50 (20.2)

65 (26.1)

Minimally improved

88 (35.6)

79 (31.7)

No change

60 (24.3)

43 (17.3)

Minimally worse

14 (5.7)

14 (5.6)

Much worse

13 (5.3)

13 (5.2)

Very much worse

6 (2.4)

4 (1.6)

P-valuec

0.0078

  1. aNumber of patients with available data for this analysis. bNumber (%) of patients. cBased on chi-square test with a modified rigid transformation.
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us